CN204039417U - A kind of organism culturing device - Google Patents
A kind of organism culturing device Download PDFInfo
- Publication number
- CN204039417U CN204039417U CN201420427381.7U CN201420427381U CN204039417U CN 204039417 U CN204039417 U CN 204039417U CN 201420427381 U CN201420427381 U CN 201420427381U CN 204039417 U CN204039417 U CN 204039417U
- Authority
- CN
- China
- Prior art keywords
- conduit
- biological
- container
- culture solution
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012258 culturing Methods 0.000 title abstract 3
- 210000004072 lung Anatomy 0.000 claims abstract description 27
- 239000012620 biological material Substances 0.000 claims abstract description 19
- 230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 16
- 238000009423 ventilation Methods 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 210000002919 epithelial cell Anatomy 0.000 claims description 5
- 210000002889 endothelial cell Anatomy 0.000 claims description 4
- 238000004088 simulation Methods 0.000 abstract description 4
- 230000000638 stimulation Effects 0.000 abstract description 4
- 230000008081 blood perfusion Effects 0.000 abstract description 3
- 230000001605 fetal effect Effects 0.000 abstract description 3
- 208000036830 Normal foetus Diseases 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract 2
- 230000000241 respiratory effect Effects 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000032646 lung growth Effects 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000003104 tissue culture media Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 230000007040 lung development Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- -1 constitute Chemical compound 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
The utility model provides a kind of organism culturing device, for the cultivation of organizational project lung, comprise main vessel, secondary container and analog breathing equipment, main vessel is used for storage organization nutrient solution and biomaterial, described biomaterial can carry out cellularised cultivation in tissue culture medium again, secondary container is for storing small airway nutrient solution, and secondary container is connected to form closed air flue respiratory cycle by the first conduit and main vessel; Analog breathing equipment passes through the second tubes connection to main vessel, for providing the simulation negative pressure ventilation of described biomaterial.Organism culturing device of the present utility model, simple to operate, the feature (blood perfusion and liquid ventilation) that Fetal Lung is grown can be simulated, create cultivation developing environment and physical stimulation environment that organizational project lung cultivates, make Acellularized valve comparable mechanical distraction force, be similar to the neccessary composition that normal fetus circulation of blood, respiratory movement and foetus lung growth are grown simulation physiological environment in cultivate.
Description
Technical Field
The utility model relates to a tissue engineering and regenerative medicine field especially relate to a biological culture apparatus of tissue engineering lung.
Background
Tissue engineering refers to the preparation of tissue and organ substitutes by using the principles and main methods of engineering science and life science to restore, maintain or improve the functions of human tissues and organs, and is a biomedical engineering application field with rapid development and profound significance.
However, the existing bioreactor has the following defects: 1. the operation is complicated; 2. the influence factor which can be exerted is single and is far away from the environment in the body.
SUMMERY OF THE UTILITY MODEL
In view of the current situation of the prior art, the utility model aims to provide a biological culture device, its simple structure can simulate the characteristics of fetal lung development (blood perfusion and liquid are ventilated), creates the cultivation development environment and the physical stimulation environment that tissue engineering lung was cultivated. In order to achieve the above purpose, the technical scheme of the utility model is as follows:
a biological culture device for the culture of tissue engineered lungs comprising:
a main container for storing a tissue culture solution and a biological material capable of being recellularly cultured in the tissue culture solution;
the auxiliary container is used for storing small-airway culture solution and is connected with the main container through a first conduit to form a closed airway breathing loop;
a simulated breathing apparatus connected to the main container by a second conduit for providing simulated negative pressure ventilation of the biological material.
Further, the biological culture device further comprises a finger-pressure pump, wherein an inlet of the finger-pressure pump is connected to the main container through a third conduit, an outlet of the finger-pressure pump is also connected with the main container through a fourth conduit, and the finger-pressure pump is used for circularly perfusing the tissue culture solution to the biological materials.
Further, a three-way valve is connected in series to the first conduit, wherein the three-way valve has a first port, a second port and a third port, the first port and the second port are connected in series to the first conduit, and the third port is connected to the secondary container through a fifth conduit.
Further, the lower end of the first conduit is positioned above the liquid level in the sub-tank, and the lower end of the fifth conduit is immersed below the liquid level in the sub-tank.
Further, valves are arranged on the third conduit and the fourth conduit.
Furthermore, the biological culture device also comprises a thermostat, and the main container, the auxiliary container and the finger pressure pump are all arranged in the thermostat.
Preferably, the biomaterial is one or more of decellularized lung scaffold, epithelial cells and endothelial cells.
Preferably, the simulated breathing apparatus is a negative pressure ventilator.
Further, the negative pressure provided by the simulated breathing device is-9 to-11 centimeters of water.
Preferably, the main container is further provided with a culture solution replacement port for replacing the culture solution.
The utility model has the advantages that:
the utility model discloses a biological culture device, and easy operation can simulate the characteristics that foetus lung develops (blood flow fills and liquid ventilates), create culture development environment and the physical stimulation environment that tissue engineering lung was cultivated, make and remove the cell support and cultivate in the simulation physiological environment of similar machinery tension force, be similar to normal foetus blood circulation, breathing motion and the essential composition that foetus lung grows and develops, satisfy the requirement that the simulation negative pressure of tissue engineering lung ventilates, promote lung epithelial cell's survival and differentiation, good basis has been established for the construction of tissue engineering artificial lung.
Drawings
FIG. 1 is a schematic structural view of an embodiment of the biological culture apparatus of the present invention.
Wherein,
1 a main vessel; 2, a secondary container; 3, simulating a breathing device; 4, a pressure pump; 5 a third conduit;
6 a fourth conduit; 7 a first conduit; 8 a fifth conduit; 9 a second conduit; 10 culture solution replacing port;
11 tissue engineering of lungs.
Detailed Description
Embodiments of the present invention are described below with reference to the drawings. Elements and features described in one drawing or one embodiment of the invention may be combined with elements and features shown in one or more other drawings or embodiments. It should be noted that the figures and descriptions have omitted, for the sake of clarity, the representation and description of components or processes that are not relevant to the present invention and known to those of ordinary skill in the art.
The present invention will be further described with reference to the accompanying drawings.
Referring to fig. 1, an embodiment of the biological culture apparatus of the present invention includes a main container 1, an auxiliary container 2 and a simulated respiration apparatus 3, wherein the main container 1 and the auxiliary container 2 are both closed containers, and the auxiliary container 2 is connected to the main container 1 through a first conduit 7 to form a closed airway respiration loop. The main container 1 is used for storing tissue culture solution and biological materials, wherein the biological materials can be subjected to recellularization culture in the tissue culture solution, and the biological materials are one or more of decellularized lung scaffolds, epithelial cells and endothelial cells. The sub-tank 2 is used to store a small airway culture solution (SAGM for short).
The utility model discloses used tissue culture liquid can carry out recellularization culture with the biomaterial of the utility model, and it can obtain on the market, also can formulate by oneself, roughly by cell basal medium, serum substitute, non-essential amino acid, L-glutamine, 2-yu zhi ethanol, basic fibroblast growth factor mainly constitute, for example, DMEM/F12 culture solution (SH30023.01B) accounts for 75-80% in the tissue culture liquid, serum substitute (10828 yu 028) accounts for 15-20%, non-essential amino acid (10Mm) accounts for 1.0-2.0%, L-glutamine (200Mm) accounts for 1.0-3.0%, 2-yu zhi ethanol accounts for 1.0-2.0%, basic fibroblast growth factor (10 μ g/ml) accounts for 0.1-0.3%.
The small airway culture solution is commercially available (such as CC-3118SAGM Bulletkit) or self-prepared, and mainly comprises 5% fetal calf serum and 350u/ml DNaseI.
The simulated breathing apparatus 3 is connected to the main container 1 by a second conduit 9 for providing simulated negative pressure ventilation of the biological material. The simulated breathing device 3 is a negative pressure respirator, and the negative pressure provided by the simulated breathing device 3 is-10 cm water column (cmH)2O), it can of course also be adjusted between-9 and-11 cm of water.
As an implementation mode, the biological culture device also comprises a finger-pressure pump 4 (finger-pressure type peristaltic pump), the inlet of the finger-pressure pump 4 is connected to the main container 1 through a third conduit 5, the outlet of the finger-pressure pump 4 is also connected to the main container 1 through a fourth conduit 6, and the finger-pressure pump 4 is used for circularly perfusing the biological materials with tissue culture solution. The finger-pressure pump 4 is arranged to circularly perfuse the biological material with tissue culture solution, so that the nutrient absorption rate of the biological material is further improved.
Preferably, a three-way valve (not shown) is arranged in series on the first conduit 7, wherein the three-way valve has a first valve port, a second valve port and a third valve port, the first valve port and the second valve port are connected in series on the first conduit 7, the third valve port is connected to the secondary container 2 through a fifth conduit 8, the three-way valve is arranged at the connection position of the first conduit 7 and the fifth conduit 8 in the figure, the lower end of the first conduit 7 is arranged above the liquid level in the secondary container 2, the lower end of the fifth conduit 8 is immersed below the liquid level in the secondary container 2, and when the inspiration phase is carried out, the lung expansion is accompanied by the suction of small airway culture liquid from the secondary container 2 through the fifth conduit 8; during the expiration phase, the lung retraction is accompanied by the expiration of the culture liquid into the sub-tank 2 through the first conduit 7 and the fifth conduit 8, or the culture liquid alone may be expired into the sub-tank 2 through the first conduit 7, or the expired culture liquid may be introduced into the three-way valve through the first conduit 7 and then expired into the sub-tank 2 from the fifth conduit 8. The three-way valve is arranged, so that the small-airway culture solution in the auxiliary container 2 is more uniform, and the dissolved oxygen level of the small-airway culture solution is improved.
As an alternative, the third conduit 5 and the fourth conduit 6 are provided with valves, i.e. one valve in series with each of the two ends of the finger pump 4 is connected to the main tank 1. The valve is arranged, so that the tightness of the main container 1 can be kept when the finger-pressure pump 4 is replaced or maintained, the test is not influenced, and the operation is convenient.
The main vessel 1 is further provided with a culture solution replacement port 10 for replacing the culture solution, so that the culture solution in the main vessel 1 can be more easily added or replaced through the culture solution replacement port 10.
When in use, the main container 1, the auxiliary container 2 and the finger-pressure pump 4 are all arranged in a thermostat, and the temperature of the thermostat is controlled between 36.5 ℃ and 37.5 ℃. The decellularized lung stent is placed in the main container 1, seed cells (such as epithelial cells, endothelial cells and the like) are respectively injected into a blood vessel and an air passage to form a tissue engineering lung 11, a finger pressure pump 4 circularly perfuses tissue culture solution to the decellularized lung stent under physiological pressure, and the simulated breathing device 3 starts to provide simulated negative pressure ventilation of the tissue engineering lung to simulate normal lung ventilation.
The biological culture device of the embodiment is simple to operate and reasonable in design, and can simulate the characteristics of fetal lung development, such as blood perfusion and liquid ventilation, and create a culture development environment and a physical stimulation environment for tissue engineering lung culture. The physical property test results show that: the perfusion error of the pulmonary artery blood vessel loop (the loop formed by the third catheter 5 and the fourth catheter 6) is small, and the finger-pressure pump operates stably; the simulated breathing device can provide negative pressure to be maintained at-9 to-11 cmH2O (centimeter water column) can meet the requirement of providing simulated negative pressure ventilation of the tissue engineering lung and lays a good foundation for the construction of the tissue engineering artificial lung.
Although the present invention and its advantages have been described in detail, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims. Moreover, the scope of the present application is not intended to be limited to the particular embodiments of the process, machine, means, methods and steps described in the specification. As one of ordinary skill in the art will readily appreciate from the disclosure of the present invention, processes, machines, means, methods, or steps, presently existing or later to be developed that perform substantially the same function or achieve substantially the same result as the corresponding embodiments described herein may be utilized according to the present invention. Accordingly, the appended claims are intended to include within their scope such processes, devices, means, methods, or steps.
Claims (10)
1. A biological culture device for the culture of tissue engineered lungs comprising:
a main container for storing a tissue culture solution and a biological material capable of being recellularly cultured in the tissue culture solution;
the auxiliary container is used for storing small-airway culture solution and is connected with the main container through a first conduit to form a closed airway breathing loop;
a simulated breathing apparatus connected to the main container by a second conduit for providing simulated negative pressure ventilation of the biological material.
2. The biological growth device of claim 1, wherein:
the device also comprises an acupressure pump, wherein an inlet of the acupressure pump is connected to the main container through a third conduit, an outlet of the acupressure pump is also connected with the main container through a fourth conduit, and the acupressure pump is used for circularly perfusing the tissue culture solution to the biological materials.
3. The biological growth device of claim 2, wherein:
and a three-way valve is connected in series on the first conduit, wherein the three-way valve is provided with a first valve port, a second valve port and a third valve port, the first valve port and the second valve port are connected in series on the first conduit, and the third valve port is connected to the secondary container through a fifth conduit.
4. The biological growth device of claim 3, wherein:
the lower end of the first conduit is positioned above the liquid level in the secondary container, and the lower end of the fifth conduit is immersed below the liquid level in the secondary container.
5. The biological growth device of claim 3, wherein:
and valves are arranged on the third conduit and the fourth conduit.
6. The biological growth device of claim 5, wherein:
the automatic water supply device further comprises a thermostat, and the main container, the auxiliary container and the finger pressure pump are all arranged in the thermostat.
7. The biological culture apparatus of any one of claims 1-6, wherein:
the biological material is one or more of decellularized lung stent, epithelial cells and endothelial cells.
8. The biological growth device of claim 7, wherein:
the simulated breathing device is a negative pressure respirator.
9. The biological growth device of claim 8, wherein:
the negative pressure provided by the simulated breathing device is-9 to-11 centimeters of water.
10. The biological culture apparatus of any one of claims 1-6, wherein: the main container is also provided with a culture solution replacing port for replacing tissue culture solution.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420427381.7U CN204039417U (en) | 2014-07-30 | 2014-07-30 | A kind of organism culturing device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201420427381.7U CN204039417U (en) | 2014-07-30 | 2014-07-30 | A kind of organism culturing device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204039417U true CN204039417U (en) | 2014-12-24 |
Family
ID=52240107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420427381.7U Expired - Fee Related CN204039417U (en) | 2014-07-30 | 2014-07-30 | A kind of organism culturing device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204039417U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104120083A (en) * | 2014-07-30 | 2014-10-29 | 中国医学科学院阜外心血管病医院 | Biological culture device |
| CN113106019A (en) * | 2021-03-15 | 2021-07-13 | 重庆医科大学 | Hydrostatic pressure bioreactor for bionic culture of nucleus pulposus tissue of intervertebral disc |
-
2014
- 2014-07-30 CN CN201420427381.7U patent/CN204039417U/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104120083A (en) * | 2014-07-30 | 2014-10-29 | 中国医学科学院阜外心血管病医院 | Biological culture device |
| CN104120083B (en) * | 2014-07-30 | 2016-04-27 | 中国医学科学院阜外心血管病医院 | A kind of organism culturing device |
| CN113106019A (en) * | 2021-03-15 | 2021-07-13 | 重庆医科大学 | Hydrostatic pressure bioreactor for bionic culture of nucleus pulposus tissue of intervertebral disc |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mol et al. | Tissue engineering of human heart valve leaflets: a novel bioreactor for a strain-based conditioning approach | |
| Sodian et al. | Tissue-engineering bioreactors: a new combined cell-seeding and perfusion system for vascular tissue engineering | |
| CN105586249B (en) | Circulating perfusion bioreactor device capable of realizing circulating perfusion of three-dimensional support | |
| JP6397473B2 (en) | Bioartificial lung | |
| Calle et al. | Procedure for lung engineering | |
| JP6829078B2 (en) | Lung bioreactor | |
| CN105494312B (en) | System and method for ex vivo lung care | |
| Hoerstrup et al. | New pulsatile bioreactor for in vitro formation of tissue engineered heart valves | |
| CN104321419B (en) | Cell culture system and cell culture processes | |
| CN104611225A (en) | Bioreactor for constructing tissue engineering liver by using in-vitro circulatory perfusion | |
| JP2012528600A5 (en) | ||
| Uzarski et al. | Dual-purpose bioreactors to monitor noninvasive physical and biochemical markers of kidney and liver scaffold recellularization | |
| Bijonowski et al. | Bioreactor design for perfusion-based, highly vascularized organ regeneration | |
| CN105142652A (en) | Human and large-mammal lung bioreactor | |
| CN204779609U (en) | Extracorporal circulatory system perfusion founds bioreactor of organizational project liver | |
| US8735143B2 (en) | Hepatic lobule-like bioreactor | |
| CN104120083B (en) | A kind of organism culturing device | |
| CN109913410A (en) | The emulation cultural method of stem cell | |
| CN204039417U (en) | A kind of organism culturing device | |
| WO2017152343A1 (en) | Recirculating perfusion bioreactor device that can realize three-dimensional scaffold recirculating perfusion | |
| CN101486968B (en) | Intellectualized bionic cultivation apparatus for tissue engineering tissue | |
| CN1257262C (en) | Pouring type biologic reactor system in vitro constructure of dual active skin | |
| Converse et al. | Bioreactors and operating room centric protocols for clinical heart valve tissue engineering | |
| Sistino | Bioreactors for tissue engineering—a new role for perfusionists? | |
| CN205241705U (en) | Organizational project cartilage in vitro culture device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141224 Termination date: 20200730 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |